Equity

6 Months Ended

Jun. 30, 2020

Stockholders' Equity Note [Abstract]

The following summarizes the changes in equity for the six months ended June 30, 2020 (dollars in thousands):



	Common stock		Additional paid-in capital			Accumulated earnings less dividends			Accumulated other comprehensive loss			Total AvalonBay stockholder's equity			Noncontrolling interests			Total equity

Balance at December 31, 2019	$	1,406	$	10,736,733		$	282,913		$	(31,503	)	$	10,989,549		$	649		$	10,990,198
Net income attributable to common stockholders	—		—			167,971			—			167,971			—			167,971
Loss on cash flow hedges, net	—		—			—			(17,603		)	(17,603		)	—			(17,603		)
Cash flow hedge losses reclassified to earnings	—		—			—			1,949			1,949			—			1,949
Change in redemption value of redeemable noncontrolling interest	—		—			471			—			471			—			471
Noncontrolling interests income allocation	—		—			—			—			—			(35		)	(35		)
Dividends declared to common stockholders ($1.59 per share)	—		—			(224,083		)	—			(224,083		)	—			(224,083		)
Issuance of common stock, net of withholdings	1		(12,492		)	(1,616		)	—			(14,107		)	—			(14,107		)
Amortization of deferred compensation	—		7,781			—			—			7,781			—			7,781
Balance at March 31, 2020	$	1,407	$	10,732,022		$	225,656		$	(47,157	)	$	10,911,928		$	614		$	10,912,542
Net income attributable to common stockholders	—		—			170,828			—			170,828			—			170,828
Loss on cash flow hedges, net	—		—			—			(1,461		)	(1,461		)	—			(1,461		)
Cash flow hedge losses reclassified to earnings	—		—			—			2,301			2,301			—			2,301
Change in redemption value of redeemable noncontrolling interest	—		—			(146		)	—			(146		)	—			(146		)
Noncontrolling interests income allocation	—		—			—			—			—			1			1
Dividends declared to common stockholders ($1.59 per share)	—		—			(224,172		)	—			(224,172		)	—			(224,172		)
Issuance of common stock, net of withholdings	—		1,050			138			—			1,188			—			1,188
Amortization of deferred compensation	—		9,724			—			—			9,724			—			9,724
Balance at June 30, 2020	$	1,407	$	10,742,796		$	172,304		$	(46,317	)	$	10,870,190		$	615		$	10,870,805

The following summarizes the changes in equity for the six months ended June 30, 2019 (dollars in thousands):



	Common stock		Additional paid-in capital		Accumulated earnings less dividends			Accumulated other comprehensive loss			Total AvalonBay stockholder's equity			Noncontrolling interests		Total equity

Balance at December 31, 2018	$	1,385	$	10,306,588	$	350,777		$	(26,144	)	$	10,632,606		$	—	$	10,632,606
Net income attributable to common stockholders	—		—		170,366			—			170,366			—		170,366
Loss on cash flow hedges, net	—		—		—			(7,231		)	(7,231		)	—		(7,231		)
Cash flow hedge losses reclassified to earnings	—		—		—			1,468			1,468			—		1,468
Change in redemption value of redeemable noncontrolling interest	—		—		(224		)	—			(224		)	—		(224		)
Dividends declared to common stockholders ($1.52 per share)	—		—		(212,166		)	—			(212,166		)	—		(212,166		)
Issuance of common stock, net of withholdings	9		143,202		(1,892		)	—			141,319			—		141,319
Amortization of deferred compensation	—		7,861		—			—			7,861			—		7,861
Balance at March 31, 2019	$	1,394	$	10,457,651	$	306,861		$	(31,907	)	$	10,733,999		$	—	$	10,733,999
Net income attributable to common stockholders	—		—		168,281			—			168,281			—		168,281
Loss on cash flow hedges, net	—		—		—			(2,888		)	(2,888		)	—		(2,888		)
Cash flow hedge losses reclassified to earnings	—		—		—			1,611			1,611			—		1,611
Change in redemption value of redeemable noncontrolling interest	—		—		(45		)	—			(45		)	—		(45		)
Noncontrolling interests income allocation	—		—		—			—			—			530		530
Dividends declared to common stockholders ($1.52 per share)	—		—		(212,549		)	—			(212,549		)	—		(212,549		)
Issuance of common stock, net of withholdings	3		50,803		—			—			50,806			—		50,806
Amortization of deferred compensation	—		10,785		—			—			10,785			—		10,785
Balance at June 30, 2019	$	1,397	$	10,519,239	$	262,548		$	(33,184	)	$	10,750,000		$	530	$	10,750,530

As of June 30, 2020 and December 31, 2019, the Company's charter had authorized for issuance a total of 280,000,000 shares of common stock and 50,000,000 shares of preferred stock.

During the six months ended June 30, 2020, the Company:


i.	issued 1,902 shares of common stock in connection with stock options exercised;


ii.	issued 1,183 common shares through the Company's dividend reinvestment plan;


iii.	issued 164,526 common shares in connection with restricted stock grants and the conversion of performance awards to restricted shares;


iv.	withheld 73,089 common shares to satisfy employees' tax withholding and other liabilities;


v.	issued 8,686 common shares through the Employee Stock Purchase Plan; and


vi.	canceled 4,050 common shares of restricted stock upon forfeiture.

Any deferred compensation related to the Company's stock option, restricted stock and performance award grants during the six months ended June 30, 2020 is not reflected on the accompanying Condensed Consolidated Balance Sheets as of June 30, 2020, and will not be reflected until recognized as compensation cost.

In May 2019, the Company commenced a fifth continuous equity program ("CEP V") under which the Company may sell (and/or enter into forward sale agreements for the sale of) up to $1,000,000,000 of its common stock from time to time. Actual sales will depend on a variety of factors to be determined by the Company, including market conditions, the trading price of the Company's common stock and determinations by the Company of the appropriate sources of funding for the Company. In conjunction with CEP V, the Company engaged sales agents who will receive compensation of up to 1.5% of the gross sales price for shares sold. The Company expects that, if entered into, it will physically settle each forward sale agreement on one or more dates specified by the Company on or prior to the maturity date of that particular forward sale agreement, in which case the Company will expect to receive aggregate net cash proceeds at settlement equal to the number of shares underlying the particular forward agreement multiplied by the relevant forward sale price. However, the Company may also elect to cash settle or net share settle a forward sale agreement. In connection with each forward sale agreement, the Company will pay the relevant forward seller, in the form of a reduced initial forward sale price, a commission of up to 1.5% of the sales prices of all borrowed shares of common stock sold. During the six months ended June 30, 2020, the Company had no sales under the program. As of June 30, 2020, the Company had $752,878,000 remaining authorized for issuance under this program.